Stericycle Inc. (NASDAQ:SRCL) had its target price reduced by Robert W. Baird from $99.00 to $85.00 in a research note issued to investors on Friday morning. They currently have a neutral rating on the stock.
SRCL has been the subject of several other reports. Macquarie assumed coverage on shares of Stericycle in a research report on Thursday, August 25th. They set a neutral rating and a $96.00 price objective for the company. Jefferies Group restated a buy rating and set a $112.50 price objective (down from $125.00) on shares of Stericycle in a research report on Wednesday, September 7th. Zacks Investment Research upgraded shares of Stericycle from a sell rating to a hold rating in a research report on Monday, July 4th. Imperial Capital downgraded shares of Stericycle from an in-line rating to an underperform rating and lowered their price target for the stock from $100.00 to $93.50 in a report on Friday, July 29th. Finally, Wellington Shields downgraded shares of Stericycle from an accumulate rating to a hold rating in a report on Friday, July 29th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and an average target price of $104.95.
Stericycle (NASDAQ:SRCL) opened at 80.26 on Friday. Stericycle has a 12-month low of $76.76 and a 12-month high of $151.57. The company has a market capitalization of $6.83 billion, a price-to-earnings ratio of 28.25 and a beta of 0.27. The firm’s 50-day moving average price is $83.43 and its 200 day moving average price is $101.33.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the consensus estimate of $1.18. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The business earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. During the same period in the previous year, the business earned $1.14 earnings per share. The company’s revenue was up 24.6% on a year-over-year basis. On average, analysts expect that Stericycle will post $4.67 earnings per share for the current year.
In other Stericycle news, Director Mark C. Miller sold 34,835 shares of the company’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the sale, the director now owns 244,284 shares of the company’s stock, valued at $25,532,563.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares in the company, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by corporate insiders.
A number of hedge funds have recently modified their holdings of SRCL. Balentine LLC boosted its stake in shares of Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock worth $127,000 after buying an additional 160 shares during the period. Pinkerton Retirement Specialists LLC purchased a new stake in shares of Stericycle during the second quarter worth approximately $131,000. Parkside Financial Bank & Trust boosted its stake in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares during the period. Meeder Asset Management Inc. purchased a new stake in shares of Stericycle during the second quarter worth approximately $155,000. Finally, Canada Pension Plan Investment Board boosted its stake in shares of Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock worth $179,000 after buying an additional 497 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.